Protocol No
NEURO-CEREVANCE-CVN424-301
Staff Member
Karen Blindauer
Phase
III
Summary
This project is being done to see whether CVN424 works better than the placebo.
Objective
CVN424 in Parkinson's Disease Participants With Motor Complications
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov